Her research will examine mental health and safety outcomes in early-onset idiopathic restless leg syndrome.
The department of pharmaceutical outcomes and policy is recruiting for new faculty at the assistant, associate, or full professor (tenure-track) rank.
Lo-Ciganic was tenured and promoted to associate professor, while Winterstein was awarded the distinguished professor title.
Schedule of events for presenters from the department of pharmaceutical outcomes and policy
The UF College of Pharmacy placed No. 3 nationally in NIH funding and total federal funding and No. 5 in total funding.
Dr. Joshua Brown is the recipient of a National Institute on Aging diversity grant supplement to collaborate with Dr. Melissa Armstrong from the UF College of Medicine.
Patient advocates argue that that opioid prescribing limits harm those people requiring the medications most.
Scott Martin Vouri, Pharm.D., Ph.D., BCPG, an assistant professor of pharmaceutical outcomes and policy, was recently awarded a K08 Career Development Award through the National Institute on Aging to further his work on prescribing cascades in older adults. Prescribing cascades describe a problem in medication use where a drug-induced…
The department of pharmaceutical outcomes and policy celebrated its 2020 and spring 2021 graduates during ceremonies in April and May.
The U.S. Food and Drug Administration in 2016 took action to reduce the overuse of fluoroquinolones, a type of antibiotic associated with serious side effects. That step helped cut the use of these antibiotics for uncomplicated urinary tract infections, or UTIs, by more than half, according to a University…